Beta-blocker prevents sudden cardiac death in patients with hemodialysis

International Journal of Cardiology

Volumn 165, Issue 3, 2013, Pages 519-522

  Matsue, Yuya ^a   Suzuki, Makoto ^a   Nagahori, Wataru ^a   Ohno, Masakazu ^a   Matsumura, Akihiko ^a   Hashimoto, Yuji ^a  

^a KAMEDA MEDICAL CENTER   (Japan)

Author keywords

Beta blocker; Dialysis; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CELIPROLOL; METOPROLOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SUDDEN CARDIAC DEATH; AGE; COMORBIDITY; CORONARY ARTERY DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; MORTALITY;

ADRENERGIC BETA-ANTAGONISTS; AGED; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84877070034     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.037     Document Type: Article

References (24)

1. A.J. Collins, R.N. Foley, and C. Herzog United States renal data system 2008 annual data report Am J Kidney Dis 53 2009 S1 S374
2. C.A. Herzog Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome Kidney Int Suppl 2003 S197 200
3. C.A. Herzog, J.M. Mangrum, and R. Passman Sudden cardiac death and dialysis patients Semin Dial 21 2008 300 307
4. A.G. Stack, and W.E. Bloembergen Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study J Am Soc Nephrol 12 2001 1516 1523
5. M.H. Rubenstein, L.C. Harrell, B.V. Sheynberg, H. Schunkert, H. Bazari, and I.F. Palacios Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102 2000 2966 2972
6. A.K. Cheung, M.J. Sarnak, and G. Yan Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study Kidney Int 65 2004 2380 2389
7. C. Wanner, V. Krane, and W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248
8. B.C. Fellstrom, A.G. Jardine, and R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
9. G. Cice, L. Ferrara, and A. D'Andrea Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial J Am Coll Cardiol 41 2003 1438 1444
10. P.H. Pun, R.W. Lehrich, S.R. Smith, and J.P. Middleton Predictors of survival after cardiac arrest in outpatient hemodialysis clinics Clin J Am Soc Nephrol 2 2007 491 500
11. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
12. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham heart study subjects Circulation 88 1993 107 115
13. L.E. Hinkle, and H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464
14. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/american heart association task force and the european society of cardiology committee for practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European heart rhythm association and the heart rhythm society Circulation 114 2006 e385 e484
15. S.K. Ganesh, A.G. Stack, N.W. Levin, T. Hulbert-Shearon, and F.K. Port Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
16. R.S. Parekh, L.C. Plantinga, and W.H. Kao The association of sudden cardiac death with inflammation and other traditional risk factors Kidney Int 74 2008 1335 1342
17. A.C. Thomas, P.A. Knapman, D.M. Krikler, and M.J. Davies Community study of the causes of "natural" sudden death BMJ 297 1988 1453 1456
18. S. Genovesi, M.G. Valsecchi, and E. Rossi Sudden death and associated factors in a historical cohort of chronic haemodialysis patients Nephrol Dial Transplant 24 2009 2529 2536
19. K.C. Abbott, F.C. Trespalacios, L.Y. Agodoa, A.J. Taylor, and G.L. Bakris beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality Arch Intern Med 164 2004 2465 2471
20. R.W. Lehrich, P.H. Pun, N.D. Tanenbaum, S.R. Smith, and J.P. Middleton Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic J Am Soc Nephrol 18 2007 312 320
21. A.J. Bleyer, J. Hartman, P.C. Brannon, A. Reeves-Daniel, S.G. Satko, and G. Russell Characteristics of sudden death in hemodialysis patients Kidney Int 69 2006 2268 2273
22. K. Takeda, A. Harada, and S. Okuda Sudden death in chronic dialysis patients Nephrol Dial Transplant 12 1997 952 955
23. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112 S119
24. A. Tun, I.A. Khan, and N. Wattanasauwan Increased regional and transmyocardial dispersion of ventricular repolarization in end-stage renal disease Can J Cardiol 15 1999 53 56